Medical Affairs Inflammation & Early Pipeline, HP ROPU ASKAN

Boehringer Ingelheim Pharmaceuticals, Inc.; Singapore; On-site; SGD 230,000 - 307,000; Full time

Job summary

Boehringer Ingelheim is seeking a seasoned Medical Affairs leader to steer regional strategy for inflammation and early pipeline assets across ASKAN. The role encompasses Australia, New Zealand, South Korea, Thailand, and Singapore, with emphasis on SK and AU/NZ for market size and reimbursement complexity.

The position requires MD/PhD/PharmD, 5+ years in Medical Affairs, and expertise in regulatory pathways, evidence generation, and cross-functional collaboration to ensure launch readiness and

Qualifications

• MD/PhD/PharmD or equivalent life sciences degree.
• Minimum 5 years in Medical Affairs, regional/multi-country experience preferred.
• Experience in inflammation/immunology or related areas is advantageous.

Responsibilities

• Act as the regional medical lead for the assigned inflammation and early pipeline assets across ASKAN.
• Lead medical strategy and execution, translating scientific insights into regional priorities and launch readiness.
• Collaborate with local medical teams, regional marketing, market access, and clinical operations to deliver an end-to-end MA launch-readiness roadmap.
• Engage with cross-functional teams to support Advisory Boards, scientific exchanges, and KEE relationship management.
• Develop regional education strategies and build deep scientific expertise on assets and disease biology.

Skills

English fluency

Cross-cultural collaboration

Strategic leadership

Education

MD/PhD/PharmD

Tools

MS Office

CRM platforms

Omnichannel tools

Job description

Boehringer Ingelheim is strengthening its Inflammation Medical Affairs presence across the ASKAN region to provide regional scientific leadership for priority pipeline assets, from early medical strategy and ecosystem readiness through launch preparation.

The geographic influence of this role encompasses Australia, New Zealand, South Korea, Thailand, and Singapore, with primary strategic priority given to South Korea and Australia/New Zealand due to market size, scientific influence, and reimbursement complexity.

This is a high-impact pipeline leadership role with end-to-end accountability for the assigned asset portfolio across the region. The majority of the role’s initial focus will be dedicated to verducatib, however, as the Inflammation and early pipeline portfolio evolves, the position will assume regional Medical Affairs leadership for any new molecule progressing into launch preparation, ensuring continuity from early scientific engagement through market readiness, evidence generation, and medical governance.

THE POSITION

Boehringer Ingelheim is strengthening its Inflammation Medical Affairs presence across the ASKAN region to provide regional scientific leadership for priority pipeline assets, from early medical strategy and ecosystem readiness through launch preparation.

The geographic influence of this role encompasses Australia, New Zealand, South Korea, Thailand, and Singapore, with primary strategic priority given to South Korea and Australia/New Zealand due to market size, scientific influence, and reimbursement complexity.

This is a high-impact pipeline leadership role with end-to-end accountability for the assigned asset portfolio across the region. The majority of the role’s initial focus will be dedicated to verducatib, however, as the Inflammation and early pipeline portfolio evolves, the position will assume regional Medical Affairs leadership for any new molecule progressing into launch preparation, ensuring continuity from early scientific engagement through market readiness, evidence generation, and medical governance.

Tasks & responsibilities

• Act as the single point of regional responsibility for all medical deliverables and scientific strategies related to the assigned Inflammation and early pipeline assets across ROPU ASKAN.
• Lead the overall medical strategy and tactical execution for the assigned portfolio, translating scientific and clinical insights into clear regional priorities, disease-area readiness, and plans to address significant unmet medical needs.
• Partner closely with local/countries medical teams, regional marketing, market access, and clinical operations to implement a cohesive, end-to-end Medical Affairs launch-readiness roadmap.
• Operate effectively within cross-functional teams: Commercial Operations, Regulatory Affairs, Market Access, Early Access Team, Clinical Development & Operations, Patient Safety & Pharmacovigilance, and Patient Engagement.
• Tailor strategic plans and resource allocation across South Korea, Australia, New Zealand, Thailand, and Singapore according to each market’s regulatory frameworks, HTA requirements, and healthcare system maturity.
• Plan, execute, and lead expert interaction platforms such as Advisory Boards, expert roundtables, consultancy groups, and market readiness panels to systematically capture critical clinical, diagnostic, access insights, and persistent unmet medical needs across all target markets.
• Build and maintain structured advocacy development plans with Key External Experts (pulmonologists, inflammatory disease specialists, CT chest radiologists) and relevant scientific societies.
• Represent BI’s scientific vision for the assigned Inflammation and early pipeline assets with excellence in communication, tailoring scientific exchange to KEEs and internal stakeholders.
• Represent BI’s scientific vision for the assigned Inflammation and early pipeline assets with excellence in communication, tailoring scientific exchange to KEEs and internal stakeholders.
• Design and execute regional medical education strategies, symposia, workshop sessions, train-the-trainer programs, and speaker tours to address key educational gaps related to disease burden, unmet medical needs, emerging science, and the clinical value of assigned pipeline assets.
• Develop and maintain deep scientific expertise in the assigned assets, their mechanisms of action, relevant disease biology, clinical development programs, and the evolving treatment landscape, remaining current on competitive dynamics and potential differentiation.
• Combine clinical insights with brand strategy to ensure all regional scientific initiatives address local unmet medical needs and support future market access.
• Lead regional evidence generation initiatives, including real-world evidence, epidemiological studies, registries, and clinical burden research, to characterize unmet medical needs and inform Health Technology Assessment and reimbursement submissions in priority markets.
• Collaborate with medical and market access teams to strengthen scientific understanding of relevant diagnostic approaches, patient identification, disease assessment, and care pathways for the assigned assets.
• Support Regional Clinical Operations with site selection, investigator engagement, feasibility assessments, and scientific input for global clinical development programs relevant to the assigned portfolio in ASKAN.
• Act as the primary regional medical point of contact for IIS and External Research Proposals, evaluating scientific merit and alignment with the regional strategy for the assigned portfolio.
• Drive omnichannel scientific engagement initiatives, leveraging digital platforms and virtual exchange tools tailored to HCP preferences across Australia, New Zealand, South Korea, Thailand, and Singapore.

Requirements

• Doctor of Medicine (MD), PharmD, or PhD in a relevant life sciences discipline.
• Minimum 5 years of Medical Affairs experience in a country-level role, and/or 2–3 years in a regional/multi-country role within the pharmaceutical industry.
• Experience or subspecialty background in Inflammation, Immunology, respiratory, or a relevant specialty area is a strong advantage, though not strictly required for candidates with proven scientific adaptability and the ability to rapidly build expertise across emerging pipeline assets.
• Experience in early access programs (compassionate use, etc.) is an advantage.
• Demonstrated experience organizing Medical Affairs initiatives: Advisory Boards, Scientific Exchange Meetings, Speaker Forums, and structured KEE relationship management.
• Proven ability to navigate matrixed organizations and manage multi-country stakeholders across varying regulatory and cultural environments.
• Strong understanding of regional regulatory pathways and reimbursement frameworks (e.g., PBAC/TGA in Australia, HIRA/MFDS in South Korea).
• English fluency is required. Korean language proficiency is a significant advantage given the strategic weight and KEE engagement depth required for the South Korea market.
• Proficiency with Microsoft Office Suite (Word, Excel, PowerPoint) and digital omnichannel engagement tools (CRM platforms, virtual meeting technology).
• Preference may be given to candidates who do not require work visa sponsorship.

Our Company

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.

Why Boehringer Ingelheim?

With us, you can develop your own path in a company with a culture that knows our differences are our strengths - and break new ground in the drive to make millions of lives better.

Here, your development is our priority. Supporting you to build a career as part of a workplace that is independent, authentic and bold, while tackling challenging work in a respectful and friendly environment where everyone is valued and welcomed.

Alongside, you have access to programs and groups that ensure your health and wellbeing are looked after - as we make major investments to drive global accessibility to healthcare. By being part of a team that is constantly innovating, you'll be helping to transform lives for generations.

Want to learn more? Visit https://www.boehringer-ingelheim.com